Brian Brohman

Brian Brohman currently serves as a Life Science Advisory Partner at Rev1 Ventures, where responsibilities include assisting affiliated companies with technology commercialization, market validation, and securing early capital investment. As a Co-Founder and Chief Business Officer of NX PharmaGen Inc., Brian has played a significant role in developing products in personalized medicine. Additionally, Brian co-founded Nexosome Oncology, focusing on real-time tumor intelligence, and previously led NX Prenatal Inc. in creating an early warning blood test for preterm birth risk. With a background that includes founding roles at NX Development Corp, Bradmer Pharmaceuticals, and Aptamera, Brian has extensive experience in business development and strategic advisory within the pharmaceutical industry. Brian holds a Bachelor of Business Administration in Finance from the University of Notre Dame and completed an Executive Education Program in M&A at The Wharton School.